Data from the study conducted by Wang et al.23demonstrated that IL‐17 was involved in the inflammatory response of IRI in acute kidney injury, and inhibition of IL‐17 might be a novel therapeutic strategy for the treatment of acute kidney injury. The gene discussed is IL17A; the disease is acute kidney injury.